Mandate

Vinge has advised Azelio in connection with a directed share issue of SEK 270 million

September 10, 2020 Capital Markets and Public M&A

Vinge has advised Azelio, a public Swedish company specialising in thermal energy storage with dispatchable and low-cost Stirling-based electricity and heat production, in connection with a directed share issue whereby Azelio raises SEK 270 million in issue proceeds before transaction costs.

The subscription price was determined to SEK 22 per share through a so called accelerated bookbuilding procedure. The share issue was directed to a number of Swedish and international institutional investors. The main purpose of the share issue is to finance the company’s ongoing operations and the continued industrialization of Azelio’s Thermal Energy Storage (TES) and Stirling-based electricity production technology, with the objective of reaching industrial volume production in 2021. Azelio’s shares are listed on Nasdaq First North Growth Market.

Vinge’s team consisted of David Andersson, William Kåge, Julia Hirschberg and Olof Löfvenberg.

Related

Vinge advises Morrow Bank AB (publ) in connection with the bank’s sale of parts of MedMera Bank and the sale of NPL portfolios

Vinge has advised Morrow Bank AB (publ) in connection with the divestment of parts of MedMera Bank’s operations to a leading global credit investment firm. The divestment is structured as a sale of shares and priced at a premium of approximately SEK 90 million above equity value as per the completion date. The transaction includes parts of MedMera’s banking operations such as IT infrastructure, organisation and management, whilst Morrow Bank retains MedMera’s performing loans, deposits, customers, the MedMera brand, the Coop partnership agreement as well as key personnel.
September 15, 2026

Vinge advises HealthCap in conjunction with its investment in AMRA Medical

HealthCap is investing in AMRA Medical AB, a company that analyses whole-body MRI images to classify and quantify an individual’s muscle and fat tissue throughout the body and places this in relation to human health and disease.
September 15, 2026

Vinge has advised EQT managed Scaleup Europe Fund on its investment in Tandem Health

Vinge has advised EQT managed Scaleup Europe Fund as lead investor in Tandem Health's USD 100 million Series B investment round, with participation from existing investors Kinnevik, Northzone, Amino Collective and Visionaries. Tandem Health is an AI healthcare company founded in 2023 and headquartered in Sweden. Tandem Health operates as an AI partner within the healthcare sector across Europe, providing AI medical assistant support to clinicians in connection with patient visits.
September 15, 2026